Literature DB >> 20378598

Impaired lung compliance and DL,CO but no restrictive ventilatory defect in sarcoidosis.

P W Boros1, P L Enright, P H Quanjer, G J J M Borsboom, S P Wesolowski, R E Hyatt.   

Abstract

Sarcoidosis is a systemic granulomatous disease with predominant manifestation in the lungs, often presenting as interstitial lung disease. Pulmonary function abnormalities in sarcoidosis include restriction of lung volumes, reduction in diffusing capacity of the lung for carbon monoxide (D(L,CO)), reduced static lung compliance (C(L,s)) and airway obstruction. The aim of the present study was to assess various lung function indices, including C(L,s) and D(L,CO), as markers of functional abnormality in sarcoidosis patients. Results from 830 consecutive patients referred for lung function tests with a diagnosis of sarcoidosis (223 in stage I, 486 in stage II and 121 in stage III) were retreospectively analysed. The mean ± sd age of the patients was 40 ± 11 yrs; 18% were active smokers and 24% were former smokers. Normal total lung capacity was found in 772 (93%) patients. Of these cases, 24.5% had a low C(L,s) and 21.5% had a low D(L,CO). At least one abnormality was observed in 39.3% of these patients, whereas, in restrictive patients, this figure was 88%. Airway obstruction was present in 11.7% of cases. Lung volumes usually remain within the normal range and measurement of either C(L,s) or D(L,CO) often reveal impaired lung function in sarcoidosis patients, even when their lung volumes are still in the normal range; these two measurements provide complementary information.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20378598     DOI: 10.1183/09031936.00166809

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  11 in total

1.  Effect of smoking and gender on pulmonary function and clinical features in sarcoidosis.

Authors:  Willane Krell; Julie M Bourbonnais; Rajat Kapoor; Lobelia Samavati
Journal:  Lung       Date:  2012-07-08       Impact factor: 2.584

2.  HO-1 protects smokers exposed to artificial stone dust for pulmonary function tests deterioration.

Authors:  Noa Ophir; Amir Bar-Shai; Mordechai R Kramer; Ahuva Grubstein; Lilach Shani Israeli; Elizabeth Fireman
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2018-04-28       Impact factor: 0.670

Review 3.  The Clinical Features of Sarcoidosis: A Comprehensive Review.

Authors:  Marc A Judson
Journal:  Clin Rev Allergy Immunol       Date:  2015-08       Impact factor: 8.667

4.  Ventilatory disturbances in patients with intrathoracic sarcoidosis - a study from a functional and histological perspective.

Authors:  Diana Calaras; Oxana Munteanu; Valentina Scaletchi; I Simionica; V Botnaru
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2017-04-28       Impact factor: 0.670

Review 5.  Diagnosis of Sarcoidosis.

Authors:  Thomas E Wessendorf; Francesco Bonella; Ulrich Costabel
Journal:  Clin Rev Allergy Immunol       Date:  2015-08       Impact factor: 8.667

6.  Characterization of the PF-ILD phenotype in patients with advanced pulmonary sarcoidosis.

Authors:  M C Schimmelpennink; D B Meek; A D M Vorselaars; L C M Langezaal; C H M van Moorsel; J J van der Vis; M Veltkamp; J C Grutters
Journal:  Respir Res       Date:  2022-06-25

7.  Oxygen desaturation during a 6-minute walk test as a predictor of maximal exercise-induced gas exchange abnormalities in sarcoidosis.

Authors:  Cecile Chenivesse; Sarah Boulanger; Carole Langlois; Lidwine Wemeau-Stervinou; Thierry Perez; Benoit Wallaert
Journal:  J Thorac Dis       Date:  2016-08       Impact factor: 2.895

8.  Characteristics of exercise capacity in female systemic lupus erythematosus associated pulmonary arterial hypertension patients.

Authors:  Bigyan Pudasaini; Guo-Ling Yang; Chen Yang; Jian Guo; Ping Yuan; Yang Wen-Lan; Rui Zhang; Lan Wang; Qin-Hua Zhao; Su-Gang Gong; Rong Jiang; Tian-Xiang Chen; Xiong Wei; Jin-Ming Liu
Journal:  BMC Cardiovasc Disord       Date:  2018-03-23       Impact factor: 2.298

9.  Coexistence of Pernicious Anemia and Myasthenia Gravis Presenting As Dyspnea.

Authors:  Sara Khademolhosseini; Elspeth Springsted; Seyedmohammad Pourshahid; Badri Giri
Journal:  Cureus       Date:  2021-05-28

10.  Cumulative Incidence and Predictors of Progression in Corticosteroid-Naïve Patients with Sarcoidosis.

Authors:  Yusuke Inoue; Naoki Inui; Dai Hashimoto; Noriyuki Enomoto; Tomoyuki Fujisawa; Yutaro Nakamura; Takafumi Suda
Journal:  PLoS One       Date:  2015-11-17       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.